×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
LS07: 5 Industry Group Joint Session:New Options in Clinical Trial Operation Model? DCT & Remote Utilization (Part 2)
Session Chair(s)
Hiroshi Matsuzawa, MSc
Clinical Development
Astellas Pharma Inc., Japan
Toshihiro Sano, RPh
Associate Vice President, Head of Clinical Operations
Merck Sharp & Dohme LLC , United States
Have an account?